RxDoctor Payments Data

Kenneth Dinella, MD

Psychiatry · Americus, GANPI 1992921126

Payments from drug & device makers

$1,472in general payments, 2019–2025

Across 74 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$307
  • Otsuka America Pharmaceutical, Inc.$195
  • Alkermes, Inc.$176
  • Vanda Pharmaceuticals Inc.$175
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$149
  • Neurocrine Biosciences, Inc.$128
  • plus $343 from 6 others

What the payments were for

  • Food & beverage$1,42597%
  • Education$473%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,472 in reported general payments places this provider in the 70th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$23,669
Medicare patients
24
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate22$66,455
Abilify MaintenaAripiprazole11$29,918
VraylarCariprazine Hcl13$17,681
Lurasidone Hcl16$4,578
Oxcarbazepine35$4,471
Lisdexamfetamine Dimesylate11$1,946
Aripiprazole31$1,270
Clonazepam33$1,255
Quetiapine Fumarate88$1,039
Methylphenidate Hcl22$973
Desvenlafaxine Succinate ErDesvenlafaxine Succinate24$819
Bupropion XlBupropion Hcl57$784
Alprazolam86$712
Ziprasidone Hcl16$543
Clozapine15$506

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$307$66,45522 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$195$29,91811 claims
Almatica Pharma LLCSertraline Hcl$24$18048 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Americus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →